Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma
Mucinous ovarian carcinoma (MOC) is a unique form of ovarian cancer. MOC typically presents at early stage but demonstrates intrinsic chemoresistance; treatment of advanced-stage and relapsed disease is therefore challenging. We harness a large retrospective MOC cohort to identify factors associated...
Enregistré dans:
Auteurs principaux: | Robert L. Hollis, Lorna J. Stillie, Samantha Hopkins, Clare Bartos, Michael Churchman, Tzyvia Rye, Fiona Nussey, Scott Fegan, Rachel Nirsimloo, Gareth J. Inman, C. Simon Herrington, Charlie Gourley |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c8786c50a23247a98138b2bae9b70e26 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic
par: Arkan Youssef, et autres
Publié: (2021) -
High frequency of BRAF mutations in primary mucinous ovarian carcinoma of Taiwanese patients
par: Wan-Ru Chao, et autres
Publié: (2021) -
Clinical and Pathological Characteristics of Mucinous Colorectal Adenocarcinoma: A Comparative Study
par: Sare Hosseini, et autres
Publié: (2016) -
Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification
par: Robert L. Hollis, et autres
Publié: (2021) -
Anti-Angiogenesis Maintenance Therapy in Newly Diagnosed and Relapsed Ovarian Cancer: A Meta-analysis of Phase III Randomized Controlled Trials
par: Yizi Wang, et autres
Publié: (2021)